Expression plasmids containing the deo promoter, and bacterial hosts containing the plasmids
CA 1309043 C · Owner: Savient Pharmaceuticals, Inc. · Inventors: Fischer, Meir
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Abstract of the Disclosure, Plasmids are provided which upon introduction into a suitable Escherichia coli host render the host capable of effecting expression of DNA encoding a desired naturallyoccurring polypeptide or polypeptide analog thereof under the control of the deo P1-P2 promoter. Further plasmids are also provided which thermoinducibly direct expression of eucaryotic genes under the control of a .lambda. PL promoter and a thermolabile repressor protein present on the same plasmids under the control of a deo P1 promoter. These plasmids have been inserted into various hosts some of, which contain DNA encoding the repressor protein. Such plasmids may be used to produce polypeptides …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted October 20, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended October 20, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.